Citations

Citations to this article as recorded by  

• FAPi-Based Agents in Thyroid Cancer: A New Step towards Diagnosis and Therapy? A Systematic Review of the Literature
  Priscilla Guglielmo, Pierpaolo Alongi, Lucia Baratto, Miriam Conte, Elisabetta Maria Abenavoli, Ambra Buschiazzo, Greta Celesti, Francesco Dondi, Rossella Filice, Joana Gorica, Lorenzo Jonghi-Lavarini, Riccardo Laudicella, Maria Librando, Flavia Linguanti
  Cancers.2024; 16(4): 839.     CrossRef
• Cancer-associated fibroblasts: protagonists of the tumor microenvironment in gastric cancer
  Ece Ozmen, Tevriz Dilan Demir, Gulnihal Ozcan
  Frontiers in Molecular Biosciences.2024;[Epub]     CrossRef
• Emerging therapeutic options for follicular-derived thyroid cancer in the era of immunotherapy
  Naimah Turner, Sarah Hamidi, Rim Ouni, Rene Rico, Ying C. Henderson, Maria Puche, Sayan Alekseev, Jocelynn G. Colunga-Minutti, Mark E. Zafereo, Stephen Y. Lai, Sang T. Kim, Maria E. Cabanillas, Roza Nurieva
  Frontiers in Immunology.2024;[Epub]     CrossRef
• Current Advances in Radioactive Iodine-Refractory Differentiated Thyroid Cancer
  Fabio Volpe, Carmela Nappi, Emilia Zampella, Erica Di Donna, Simone Maurea, Alberto Cuocolo, Michele Klain
  Current Oncology.2024; 31(7): 3870.     CrossRef
• New insights into the mechanisms of the extracellular matrix and its therapeutic potential in anaplastic thyroid carcinoma
  Jinkun Xia, Yuyu Shi, Xinxu Chen
  Scientific Reports.2024;[Epub]     CrossRef
• Improving the diagnostic strategy for thyroid nodules: a combination of artificial intelligence-based computer-aided diagnosis system and shear wave elastography
  Ziman Chen, Nonhlanhla Chambara, Xina Lo, Shirley Yuk Wah Liu, Simon Takadiyi Gunda, Xinyang Han, Michael Tin Cheung Ying
  Endocrine.2024;[Epub]     CrossRef
• Co-cultivation of human granulosa cells with ovarian cancer cells leads to a significant increase in progesterone production
  Detlef Pietrowski, Martina Grgic, Isabella Haslinger, Julian Marschalek, Christian Schneeberger
  Archives of Gynecology and Obstetrics.2023; 307(5): 1593.     CrossRef
• Secretome of Stromal Cancer-Associated Fibroblasts (CAFs): Relevance in Cancer
  Deepshikha Mishra, Debabrata Banerjee
  Cells.2023; 12(4): 628.     CrossRef
• Head-to-Head Comparison of [68Ga]Ga-DOTA.SA.FAPi and [68Ga]Ga-DOTANOC Positron Emission Tomography/Computed Tomography Imaging for the Follow-Up Surveillance of Patients with Medullary Thyroid Cancer
  Sanjana Ballal, Madhav Prasad Yadav, Frank Roesch, Shobhana Raju, Swayamjeet Satapathy, Parvind Sheokand, Euy Sung Moon, Marcel Martin, Shipra Awarwal, Madhavi Tripathi, Chandrasekhar Bal
  Thyroid®.2023; 33(8): 974.     CrossRef
• Head-to-head comparison of [68Ga]Ga-DOTA.SA.FAPi with [18F]F-FDG PET/CT in radioiodine-resistant follicular-cell derived thyroid cancers
  Sanjana Ballal, Madhav P. Yadav, Frank Roesch, Swayamjeet Satapathy, Euy Sung Moon, Marcel Martin, Nicky Wakade, Parvind Sheokand, Madhavi Tripathi, Kunal R. Chandekar, Shipra Agarwal, Ranjit Kumar Sahoo, Sameer Rastogi, Chandrasekhar Bal
  European Journal of Nuclear Medicine and Molecular Imaging.2023; 51(1): 233.     CrossRef
• Identifying the cancer-associated fibroblast signature to predict the prognosis and immunotherapy response in patients with lung squamous cell carcinoma
  Yinhui Zhu, Yingqun Zhu, Sirui Chen, Qian Cai
  Computer Methods in Biomechanics and Biomedical Engineering.2023; : 1.     CrossRef
• Roles and new Insights of Macrophages in the Tumor Microenvironment of Thyroid Cancer
  Qi Liu, Wei Sun, Hao Zhang
  Frontiers in Pharmacology.2022;[Epub]     CrossRef
• Rab22a Promotes Epithelial‐Mesenchymal Transition in Papillary Thyroid Carcinoma by Activating PI3K/AKT/mTOR Signaling Pathway
  Xue Luo, Jinping Wang, Jinxi Lu, Xi Wang, Yuan Miao, Qingchang Li, Xiaoman Li, Liang Wang, Yong Xin Ma
  BioMed Research International.2022;[Epub]     CrossRef
• Extracellular vesicles from thyroid cancer harbor a functional machinery involved in extracellular matrix remodeling
  Rocío del Carmen Bravo-Miana, María Florencia Soler, Danilo Guillermo Ceschin, Félix Royo, Dana María Negretti-Borga, Mikel Azkargorta, Félix Elortza, María del Mar Montesinos, Claudia Gabriela Pellizas, Juan Manuel Falcón-Pérez, Ana Carolina Donadio
  European Journal of Cell Biology.2022; 101(3): 151254.     CrossRef
• The clinical significance of thyroid hormone-responsive in thyroid carcinoma and its potential regulatory pathway
  Zhen-xing Yu, Cheng Xiang, Sheng-gui Xu, Yang-ping Zhang
  Medicine.2022; 101(31): e29972.     CrossRef
• Thyroid Cancer and Fibroblasts
  Angelica Avagliano, Giuseppe Fiume, Claudio Bellevicine, Giancarlo Troncone, Alessandro Venuta, Vittoria Acampora, Sabrina De Lella, Maria Rosaria Ruocco, Stefania Masone, Nunzio Velotti, Pietro Carotenuto, Massimo Mallardo, Carmen Caiazza, Stefania Monta
  Cancers.2022; 14(17): 4172.     CrossRef
• TIM3 Expression in Anaplastic-Thyroid-Cancer-Infiltrating Macrophages: An Emerging Immunotherapeutic Target
  Luz Maria Palacios, Victoria Peyret, María Estefania Viano, Romina Celeste Geysels, Yair Aron Chocobar, Ximena Volpini, Claudia Gabriela Pellizas, Juan Pablo Nicola, Claudia Cristina Motran, María Cecilia Rodriguez-Galan, Laura Fozzatti
  Biology.2022; 11(11): 1609.     CrossRef
• Recent progress in molecular mechanisms of postoperative recurrence and metastasis of hepatocellular carcinoma
  Zhao-Shan Niu, Wen-Hong Wang, Xiao-Jun Niu
  World Journal of Gastroenterology.2022; 28(46): 6433.     CrossRef
• Recent advances in regenerative medicine strategies for cancer treatment
  Vahid Mansouri, Nima Beheshtizadeh, Maliheh Gharibshahian, Leila Sabouri, Mohammad Varzandeh, Nima Rezaei
  Biomedicine & Pharmacotherapy.2021; 141: 111875.     CrossRef
• Secreted Factors by Anaplastic Thyroid Cancer Cells Induce Tumor-Promoting M2-like Macrophage Polarization through a TIM3-Dependent Mechanism
  Cinthia Carolina Stempin, Romina Celeste Geysels, Sunmi Park, Luz Maria Palacios, Ximena Volpini, Claudia Cristina Motran, Eva Virginia Acosta Rodríguez, Juan Pablo Nicola, Sheue-yann Cheng, Claudia Gabriela Pellizas, Laura Fozzatti
  Cancers.2021; 13(19): 4821.     CrossRef
• Novel Fibroblast Activation Protein Inhibitor-Based Targeted Theranostics for Radioiodine-Refractory Differentiated Thyroid Cancer Patients: A Pilot Study
  Sanjana Ballal, Madhav Prasad Yadav, Euy Sung Moon, Frank Roesch, Samta Kumari, Shipra Agarwal, Madhavi Tripathi, Ranjit Kumar Sahoo, Bharadwaj Srinivas Mangu, Avinash Tupalli, Chandrasekhar Bal
  Thyroid.2021;[Epub]     CrossRef
• Emerging Biomarkers in Thyroid Practice and Research
  Shipra Agarwal, Andrey Bychkov, Chan-Kwon Jung
  Cancers.2021; 14(1): 204.     CrossRef

The incidence of thyroid cancer is growing the fastest among all cancers in the United States, especially in women. The number of patients with thyroid neoplasm is part of an even larger number of patients who often need to undergo an operation to exclude a cancer diagnosis. While differentiated thyroid cancer (papillary thyroid cancer and follicular thyroid cancer) accounts for most cases of thyroid cancer and has a relatively good prognosis, effective treatments for patients with de-differentiated and anaplastic thyroid cancer are still gravely needed. Despite progress in the identification of genetic changes in thyroid cancer, the impact of aberrant epigenetic alterations on thyroid cancer remains to be fully elucidated. Understanding of the roles of epigenetic changes in thyroid cancer could open new opportunities for the identification of innovative molecular targets for novel treatment modalities, especially for anaplastic thyroid cancer for which treatment is very limited. This article briefly reviews the studies that exemplify the potential for and promise of using epigenetic regulators in the treatment of thyroid cancer.

Citations

Citations to this article as recorded by  

• Challenges and Coping Strategies of Older Adults in the Aftermath of Kahramanmaraş Earthquake in Türkiye: A Qualitative Research
  Nilgun Kuru Alici, Bilge Kalanlar
  Journal of Applied Gerontology.2024; 43(10): 1580.     CrossRef
• The role of epigenetic methylations in thyroid Cancer
  Xiaojie Yu, Hao Zhang, Haojie Zhang, Changran Hou, Xiaohong Wang, Pengfei Gu, Yong Han, Zhenlin Yang, Weiwei Zou
  World Journal of Surgical Oncology.2024;[Epub]     CrossRef
• CircRTN1 stimulates HMGB1 to regulate the malignant progression of papillary thyroid cancer by sponging miR-101-3p
  Mei Zheng, Lingli Xu, Cuifeng Wei, Wenzhen Guan
  Hormones.2023; 22(2): 281.     CrossRef
• The expression of HDAC9 and P300 in papillary thyroid carcinoma cell line
  Hatice Ozisik, Berrin Ozdil, Aslı Suner, Murat Sipahi, Mehmet Erdogan, Sevki Cetinkalp, Gokhan Ozgen, Fusun Saygili, Gulgun Oktay, Huseyin Aktug
  Pathology - Research and Practice.2023; 243: 154385.     CrossRef
• Dynamic Cancer Cell Heterogeneity: Diagnostic and Therapeutic Implications
  Valerie Jacquemin, Mathieu Antoine, Geneviève Dom, Vincent Detours, Carine Maenhaut, Jacques E. Dumont
  Cancers.2022; 14(2): 280.     CrossRef
• Thyroid Carcinoma: A Review for 25 Years of Environmental Risk Factors Studies
  Eva Kruger, Eman A. Toraih, Mohammad H. Hussein, Shaimaa A. Shehata, Amani Waheed, Manal S. Fawzy, Emad Kandil
  Cancers.2022; 14(24): 6172.     CrossRef
• Study of Essential and Toxic Metal Imbalances in the Scalp Hair of Thyroid Cancer Patients in Comparison with Healthy Donors
  Kalsoom Bibi, Munir H. Shah
  Biological Trace Element Research.2021; 199(2): 500.     CrossRef
• Modern concepts of the molecular pathogenesis of thyroid cancer
  A. A. Mikhailova, A. V. Shestakov, K. A. Chubakova, E. V. Kolokolova, V. Yu. Eliseev, M. Ya. Kostyaeva, E. G. Akperov, V. E. Pilipenko, T. V. Saprina, M. R. Mukhamedov, E. L. Choinzonov
  Advances in Molecular Oncology.2021; 8(2): 8.     CrossRef
• Effect of valproic acid on miRNAs affecting histone deacetylase in a model of anaplastic thyroid cancer
  Nur Selvi Gunel, Nihal Birden, Cansu Caliskan Kurt, Bakiye Goker Bagca, Behrouz Shademan, Fatma Sogutlu, Neslihan Pinar Ozates, Cigir Biray Avci
  Molecular Biology Reports.2021; 48(8): 6085.     CrossRef
• Histone Deacetylase Inhibitors and Papillary Thyroid Cancer
  Eleftherios Spartalis, Konstantinos Kotrotsios, Dimosthenis Chrysikos, Michael Spartalis, Stavroula A. Paschou, Dimitrios Schizas, Konstantinos Tsamakis, Dimitrios Dimitroulis, Theodore Troupis, Nikolaos Nikiteas
  Current Pharmaceutical Design.2021; 27(18): 2199.     CrossRef
• HDAC1 and HDAC2 Double Knockout Triggers Cell Apoptosis in Advanced Thyroid Cancer
  Ching-Ling Lin, Ming-Lin Tsai, Chun-Yu Lin, Kai-Wen Hsu, Wen-Shyang Hsieh, Wei-Ming Chi, Li-Chi Huang, Chia-Hwa Lee
  International Journal of Molecular Sciences.2019; 20(2): 454.     CrossRef
• Systems Biology Approaches to Investigate Genetic and Epigenetic Molecular Progression Mechanisms for Identifying Gene Expression Signatures in Papillary Thyroid Cancer
  Shan-Ju Yeh, Chien-Yu Lin, Cheng-Wei Li, Bor-Sen Chen
  International Journal of Molecular Sciences.2019; 20(10): 2536.     CrossRef
• Human telomerase reverse transcriptase in papillary thyroid cancer: gene expression, effects of silencing and regulation by BET inhibitors in thyroid cancer cells
  Valentina Maggisano, Marilena Celano, Saverio Massimo Lepore, Marialuisa Sponziello, Francesca Rosignolo, Valeria Pecce, Antonella Verrienti, Federica Baldan, Catia Mio, Lorenzo Allegri, Marianna Maranghi, Rosa Falcone, Giuseppe Damante, Diego Russo, Stef
  Endocrine.2019; 63(3): 545.     CrossRef
• Role of Emerging Environmental Risk Factors in Thyroid Cancer: A Brief Review
  Maria Fiore, Gea Oliveri Conti, Rosario Caltabiano, Antonino Buffone, Pietro Zuccarello, Livia Cormaci, Matteo Angelo Cannizzaro, Margherita Ferrante
  International Journal of Environmental Research and Public Health.2019; 16(7): 1185.     CrossRef